NxStage PureFlow B Solution - Premixed Dialysate for Hemodialysis with NxStage System One
FDA Device Recall #Z-1132-2018 — Class II — November 10, 2017
Recall Summary
| Recall Number | Z-1132-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | November 10, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | NxStage Medical, Inc. |
| Location | Lawrence, MA |
| Product Type | Devices |
| Quantity | 1243400 units |
Product Description
NxStage PureFlow B Solution - Premixed Dialysate for Hemodialysis with NxStage System One
Reason for Recall
Using different fluid formulations of NxStage PureFlow B Solution at the same time during treatment may cause patient health risk. The NxStage PureFlow B Solution is for use with systems that use one premixed dialysate during hemodialysis. The original labeling did not warn against mixing dialysate formulations and did not instruct staff to verify that the fluid is flowing during use.
Distribution Pattern
US nationwide distribution
Lot / Code Information
RFP-400 - M535RFP4000 RFP-400-BB - 00842289101258 RFP-401 M - 535RPF4010 RFP-401-BB - 00842289101265 RFP-402 - M535RFP4020 RFP-403 - M535RFP4030 RFP-404- M535RFP4040 RFP-405 - M535RFP4050 RFP-406 - M535RFP4060 RFP-453 - M535RFP4530 RFP-454 - M535RFP4540 RFP-455 - M535RFP4550 RFP-456 - M535RFP4560
Other Recalls from NxStage Medical, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0697-2020 | Class II | Low Volume Cartridge IFU (SKU CAR-125-B) used w... | Aug 27, 2019 |
| Z-1706-2019 | Class II | NxStage PureFlow B Solution, REF RFP-400, M535R... | Apr 11, 2019 |
| Z-1707-2019 | Class II | NxStage PureFlow B Solution, REF RFP-401, M535R... | Apr 11, 2019 |
| Z-0502-2019 | Class II | NxStage PureFlow B Solution-RFP-402, Premixed D... | Oct 17, 2018 |
| Z-0500-2019 | Class II | NxStage PureFlow B Solution-RFP-400, Premixed D... | Oct 17, 2018 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.